Hydrochloric Acid

Hydrochloric Acid

SCHEMBL11275

Cl.ClCCN1CCOCC1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA known ✓ P06280 1/20 0.50
SIGMAR1 known ✓ Q99720 2/20 0.41
HRH3 known ✓ Q9Y5N1 1/20 0.40
CA2 known ✓ P00918 1/20 0.39
ALDH1A1 P00352 3/20 0.50
KDM4E B2RXH2 3/20 0.50
KEAP1 Q14145 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
USP2 O75604 2/20 0.41
HPGD P15428 1/20 0.41
DUSP3 P51452 1/20 0.41
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA9 Q16790 1/20 0.39
POLB P06746 1/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9703482 1.00 ALDH1A1 (0.50) ALDH1A1KDM4EGLAKEAP1SMN1; SMN2
Hydrochloric Acid SCHEMBL28756894 0.97 GLA (0.48) ALDH1A1KDM4EGLAKEAP1SMN1; SMN2
SCHEMBL40041 0.97
Hydrochloric Acid SCHEMBL1448214 0.92 ALDH1A1 (0.48) ALDH1A1KDM4EGLAKEAP1SMN1; SMN2
SCHEMBL31547876 0.88 GLA (0.45) ALDH1A1KDM4EGLAKEAP1SMN1; SMN2
SCHEMBL27683729 0.88 HRH3 (0.48) ALDH1A1KDM4EGLAKEAP1SMN1; SMN2
Hydrochloric Acid SCHEMBL10978 0.85 KEAP1 (0.58) ALDH1A1KDM4EGLAKEAP1SMN1; SMN2
Hydrochloric Acid SCHEMBL8950153 0.84 GLA (0.39) ALDH1A1KDM4EGLAKEAP1SMN1; SMN2
SCHEMBL235080 0.83 KDM4E (0.65) ALDH1A1KDM4EGLAKEAP1SMN1; SMN2
Dimethylformamide SCHEMBL1788685 0.82 GLA (0.42) ALDH1A1KDM4EGLAKEAP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4495 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4302831-B1 PROCESS FOR SYNTHESIS OF TIRBANIBULIN TRIFARMA S P A (IT) 2025-08-27 EP claimed
CN-115028582-B Preparation method of N-aryl pyrazole medicine E-52862 and product thereof 曲靖师范学院 2024-04-12 CN claimed
CN-117384198-A BODIPY-based lysosome targeting near infrared fluorescent probe for detecting hypochlorous acid as well as preparation method and application thereof 南京林业大学 2024-01-12 CN claimed
WO-2024008625-A1 PROCEDURE FOR THE SYNTHESIS OF TIRBANIBULIN TRIFARMA S.P.A. (IT) 2024-01-11 WO claimed
EP-4302831-A1 PROCESS FOR SYNTHESIS OF TIRBANIBULIN Trifarma S.p.A. (IT) 2024-01-10 EP claimed
CN-115748003-B High-hygroscopicity regenerated PET (polyethylene terephthalate) fiber and processing technology thereof 江苏中石纤维股份有限公司 2023-10-10 CN claimed
CN-116554109-A Inhibitors of bruton's tyrosine kinase and methods of preparing the same 中山大学 2023-08-08 CN claimed
CN-116496244-A Lysosome targeting nitroreductase responsive fluorescent probe based on triphenylamine skeleton and synthesis method and application thereof 宁波大学附属第一医院 2023-07-28 CN claimed
CN-115748003-A High-moisture-absorption regenerated PET (polyethylene terephthalate) fiber and processing technology thereof 江苏中石纤维股份有限公司 2023-03-07 CN claimed
CN-115028582-A Preparation method and product of N-aryl pyrazole medicine E-52862 曲靖师范学院 2022-09-09 CN claimed
CN-1370170-A DNA methyltransferase inhibitors PENN STATE RES FOUND (US) 2002-09-18 CN claimed
EP-0743574-B1 Migration imaging members XEROX CORP (US) 2000-12-27 EP claimed
EP-0743573-B1 Method for obtaining image contrast migration imaging members XEROX CORP (US) 2000-09-06 EP claimed
EP-0743573-A2 Method for obtaining image contrast migration imaging members XEROX CORPORATION (US) 1996-11-20 EP claimed
EP-0743574-A2 Migration imaging members XEROX CORPORATION (US) 1996-11-20 EP claimed
US-5563014-A SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT XEROX CORPORATION (US) 1996-10-08 US claimed
US-5514505-A SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE XEROX CORPORATION (US) 1996-05-07 US claimed
EP-0426987-B1 RAPIDLY IMMOBILIZING PAPER COATING COMPOSITIONS National Starch and Chemical Investment Holding Corporation (US) 1993-07-14 EP claimed
EP-0426987-A1 Rapidly immobilizing paper coating compositions National Starch and Chemical Investment Holding Corporation (US) 1991-05-15 EP claimed
EP-0153160-A1 Novel cytotoxic aminoalkyl phenol ethers The University of Manitoba (CA) 1985-08-28 EP claimed